936249-31-9 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-Methoxyethyl)-1H-Pyrazole-5-Carboxylic Acid is used as a pharmaceutical compound for its potential role in the development of new drugs. Its anti-inflammatory and anticancer properties make it a promising candidate for targeting specific biological pathways involved in these conditions.
Used in Drug Design and Development:
In the field of drug design and development, 1-(2-Methoxyethyl)-1H-Pyrazole-5-Carboxylic Acid is utilized as a key component in the creation of novel therapeutic agents. Its structure allows for the possibility of interaction with enzymes or receptors, which can be exploited to design drugs that modulate these targets for treating various diseases, including inflammation and cancer.
Used in Research and Development:
1-(2-Methoxyethyl)-1H-Pyrazole-5-Carboxylic Acid serves as a valuable compound in research and development, particularly in the study of its biological activity and potential medicinal applications. Further investigation into its interactions with biological systems can lead to a better understanding of its therapeutic potential and the development of more effective treatments for various health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 936249-31-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,2,4 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 936249-31:
(8*9)+(7*3)+(6*6)+(5*2)+(4*4)+(3*9)+(2*3)+(1*1)=189
189 % 10 = 9
So 936249-31-9 is a valid CAS Registry Number.
936249-31-9Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS AHR MODULATORS
-
Page/Page column 16; 17, (2020/03/24)
The present invention relates compounds of the general formula (I) or (III) which are ARH inhibitors, methods for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds and pharmaceutical compositions for the treatment or prevention of diseases, in particular cancer or conditions with dysregulated immune functions, or other conditions associated with aberrant AHR signalling, as a sole agent of in combination with other active ingredients. Such compounds may also be of utility in the expansion of hematopoietic stem cells (HSCs) and the use of HSCs in autologous or allogenic transplantation for the treatment of patients with inherited immunological and autoimmune diseases and diverse hematopoietic disorders.
Pyrazine Derivatives
-
Page/Page column 32, (2008/06/13)
The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
